Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ-151 Cream 0.3% in Pediatric Subjects With Plaque Psoriasis
NCT04746911Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Mar 2021
- Primary completion
- May 2022
- Countries
- 3
01
Overview
A Phase 2 trial of roflumilast vehicle cream in plaque psoriasis, sponsored by Arcutis Biotherapeutics. Started Mar 2021; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04746911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04746911.